Skip to main content

Diagnostic options · UAE

Single Gene tests in Dubai & UAE

Compare available Single Gene tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

332

Listed price range

2,000.00–2,800.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Single Gene test prices

Showing 181–195 of 332 matching tests.

Single Gene diagnostic tests, details, and listed prices
Test and description Specimen Typical duration Price Options
TEST-4796
MBD5 Gene Mental Retardation, Autosomal Dominant Type 1 Genetic Test

This genetic test identifies pathogenic variants in the MBD5 gene, which are associated with autosomal dominant intellectual disability, developmental delay, and autism spectrum fe...

Whole Blood (Peripheral) 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the MBD5 gene", "Single-nucleotide variants", "Insertions/Deletions (indels)"]
Parameters
[]
Preparation
["No specific fasting required", "Inform phlebotomist of any medications"]
Indications
["Suspected MBD5-related disorder", "Family history of MBD5-related disorder", "Need for genetic diagnosis for early intervention", "Family planning"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21613-7 ICD-10: F79
Clinical summary
This genetic test identifies pathogenic variants in the MBD5 gene, which are associated with autosomal dominant intellectual disability, developmental delay, and autism spectrum features.
TEST-4903
MECP2 Gene Analysis (X-Linked Mental Retardation Type 13) NGS Test

This test identifies pathogenic variants, including single nucleotide variants, insertions/deletions, and copy number variations, within the MECP2 gene.

Whole blood (EDTA tube), extracted DNA, or FTA card 3 – 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["MECP2 gene sequence", "Copy Number Variations (CNV) in MECP2 gene", "Pathogenic variants in MECP2 gene"]
Parameters
[]
Preparation
["Mandatory pre-test genetic counseling session required.", "No fasting required.", "Completed clinical history form required."]
Indications
["Suspected Rett syndrome", "Suspected X-linked intellectual disability", "Developmental delay or regression", "Family history of MECP2-related disorders"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21679-7 ICD-10: F84.2, F72
Clinical summary
This test identifies pathogenic variants, including single nucleotide variants, insertions/deletions, and copy number variations, within the MECP2 gene.
TEST-3814
MECP2 Gene Angelman-Like Syndrome Genetic Test

This test identifies pathogenic variants within the MECP2 gene, which are associated with an Angelman syndrome-like phenotype.

Whole Blood (EDTA), Extracted DNA, or FTA Card Blood Spot 3 to 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the MECP2 gene", "Single-nucleotide variants", "Copy number changes"]
Parameters
[]
Preparation
[]
Indications
["Suspected Angelman-like syndrome", "Unexplained neurodevelopmental delay", "Ataxia", "Absent speech"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 83491-7 ICD-10: Q93.5
Clinical summary
This test identifies pathogenic variants within the MECP2 gene, which are associated with an Angelman syndrome-like phenotype.
TEST-4487
MED12 Gene FG Syndrome Type 1 Genetic Testing (NGS) Test

This test detects pathogenic variants in the MED12 gene associated with FG syndrome type 1 using Next-Generation Sequencing.

Peripheral whole blood (EDTA), extracted DNA, or FTA card 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in MED12 gene coding regions", "Pathogenic variants in MED12 gene splice sites"]
Parameters
[]
Preparation
["Pre-test genetic counselling session is mandatory"]
Indications
["Suspected FG syndrome type 1", "Family history of FG syndrome type 1"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 87422-4 ICD-10: Q87.8
Clinical summary
This test detects pathogenic variants in the MED12 gene associated with FG syndrome type 1 using Next-Generation Sequencing.
TEST-3993
MED13L Gene Sequencing (NGS) Test

This diagnostic test detects pathogenic variants in the MED13L gene linked to dextro‑looped transposition of the great arteries (D‑TGA).

Whole Blood (EDTA), Extracted DNA, or FTA Card 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the MED13L gene", "Single-nucleotide variants", "Small indels", "Copy number variants"]
Parameters
[{"name": "Diagnostic Sensitivity", "reference_range": "99.9% for single-nucleotide variants/copy number changes"}, {"name": "Read Depth", "reference_range": "Average 100x"}]
Preparation
["Mandatory genetic counseling & family pedigree required before testing"]
Indications
["Individuals with a family history of transposition of the great arteries", "Parents of an affected child", "Patients with suggestive congenital heart defects", "Asymptomatic relatives planning pregnancy"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 93218-8 ICD-10: Q20.3
Clinical summary
This diagnostic test detects pathogenic variants in the MED13L gene linked to dextro‑looped transposition of the great arteries (D‑TGA).
TEST-5095
MGME1 Gene Mitochondrial DNA Depletion Syndrome Type 11 Genetic Test

This test identifies pathogenic variants in the MGME1 gene associated with Mitochondrial DNA Depletion Syndrome Type 11.

Whole Blood (EDTA), Extracted DNA, or One Drop of Blood on FTA Card 3 – 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the MGME1 gene", "Point mutations", "Small insertions/deletions"]
Parameters
[]
Preparation
["A clinical history review is required", "A genetic counselling session is required to construct a family pedigree"]
Indications
["Suspected Mitochondrial DNA Depletion Syndrome Type 11", "Infantile neurodegenerative disorder", "Family history of MGME1-related disorders"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81200-1 ICD-10: E88.41
Clinical summary
This test identifies pathogenic variants in the MGME1 gene associated with Mitochondrial DNA Depletion Syndrome Type 11.
TEST-2582
MMP9 Gene, Metaphyseal Anadysplasia Type 2, Genetic Test

This genetic test identifies pathogenic mutations in the MMP9 gene associated with Metaphyseal Anadysplasia Type 2.

Peripheral Whole Blood, Extracted DNA, or FTA Card Dried Blood Spot 3 to 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic mutations in the MMP9 gene", "Single nucleotide variants", "Indels", "Copy number changes"]
Parameters
[]
Preparation
["Pre-test genetic counselling is required", "Informed consent must be obtained"]
Indications
["Suspected Metaphyseal Anadysplasia Type 2", "Genetic counselling for families with skeletal dysplasia", "Prenatal diagnosis"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21655-2 ICD-10: Q78.8, Q78.5
Clinical summary
This genetic test identifies pathogenic mutations in the MMP9 gene associated with Metaphyseal Anadysplasia Type 2.
TEST-5752
MOCOS Gene (Xanthinuria Type 2) Genetic Test

This test identifies pathogenic variants in the MOCOS gene, confirming a diagnosis of Xanthinuria Type 2.

Whole Blood, Extracted DNA, or FTA Card (Dried Blood Spot) 3 to 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the MOCOS gene"]
Parameters
[]
Preparation
["Clinical history document required", "Mandatory genetic counselling session"]
Indications
["Symptomatic patients with suspected Xanthinuria Type 2", "Family screening for at-risk relatives", "Reproductive planning"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 101513-5 ICD-10: E79.8, Z15.09, Z13.8
Clinical summary
This test identifies pathogenic variants in the MOCOS gene, confirming a diagnosis of Xanthinuria Type 2.
TEST-6312
MPDU1 Gene Glycosylation Disorder Type 1F Genetic Test

This test identifies pathogenic variants in the MPDU1 gene associated with Congenital Disorder of Glycosylation Type If (CDG-If). It provides a definitive molecular diagnosis for m...

Whole blood (EDTA) or buccal swab 3 – 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["MPDU1 gene variants", "Single-nucleotide variants (SNVs)", "Insertions/deletions (indels)", "Copy-number variations (CNVs)"]
Parameters
[]
Preparation
["No specific fasting required", "Do not stop, start, or modify any medication or therapeutic regimen without explicit guidance from the referring physician"]
Indications
["Suspected congenital disorder of glycosylation type If (CDG-If)", "Need for definitive molecular diagnosis", "Genetic counselling", "Family risk assessment"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 95407-5 ICD-10: E77.8
Clinical summary
This test identifies pathogenic variants in the MPDU1 gene associated with Congenital Disorder of Glycosylation Type If (CDG-If). It provides a definitive molecular diagnosis for metabolic management and genetic counselling.
TEST-4515
MPLKIP Gene Trichothiodystrophy, Nonphotosensitive Type 1, Genetic Test

This genetic test evaluates the MPLKIP gene for pathogenic variants associated with Trichothiodystrophy, nonphotosensitive type 1.

Whole Blood, Extracted DNA, or FTA Card 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the MPLKIP gene"]
Parameters
[]
Preparation
["No dietary or medication restrictions are required."]
Indications
["Suspected Trichothiodystrophy, nonphotosensitive type 1", "Family history of Trichothiodystrophy, nonphotosensitive type 1", "Carrier screening"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21636-6 ICD-10: Q84.1
Clinical summary
This genetic test evaluates the MPLKIP gene for pathogenic variants associated with Trichothiodystrophy, nonphotosensitive type 1.
TEST-6166
MRPS22 Gene Combined Oxidative Phosphorylation Deficiency Type 5 Genetic Test

This genetic test identifies pathogenic variants in the MRPS22 gene associated with Combined Oxidative Phosphorylation Deficiency Type 5 (COXPD5).

Whole Blood (EDTA) or FTA Card 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the MRPS22 gene"]
Parameters
[]
Preparation
["No fasting is necessary.", "Do not discontinue prescribed medication without consulting your physician."]
Indications
["Suspected Combined Oxidative Phosphorylation Deficiency Type 5 (COXPD5)", "Family history of mitochondrial disorders", "Evaluation of unexplained neurological or metabolic symptoms"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 93935-3 ICD-10: E88.49
Clinical summary
This genetic test identifies pathogenic variants in the MRPS22 gene associated with Combined Oxidative Phosphorylation Deficiency Type 5 (COXPD5).
TEST-2536
MSMO1 Gene Microcephaly Genetic Test

This test evaluates the MSMO1 gene for pathogenic variants associated with primary microcephaly, congenital cataracts, and intellectual disability.

Peripheral Whole Blood, Extracted DNA, or FTA Card Blood Spot 3 to 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["MSMO1 gene sequence", "Pathogenic variants (SNVs, indels, CNVs)"]
Parameters
[]
Preparation
[]
Indications
["Unexplained microcephaly", "Microcephaly with congenital cataracts", "Microcephaly with developmental delay"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21636-5 ICD-10: Q02, Q12.0
Clinical summary
This test evaluates the MSMO1 gene for pathogenic variants associated with primary microcephaly, congenital cataracts, and intellectual disability.
TEST-2229
MSX1 Gene Tooth Agenesis, Selective Type 1 Genetic Test

This genetic test analyzes the MSX1 gene to identify variants associated with selective tooth agenesis (congenital absence of permanent teeth). It utilizes Next-Generation Sequenci...

Whole Blood (Peripheral) or Buccal Swab 3 to 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["MSX1 gene variants", "Single nucleotide variants (SNVs)", "Small insertions/deletions (indels)", "Copy number variants (CNVs)"]
Parameters
[]
Preparation
["No specific fasting required", "Inform phlebotomist about current medications"]
Indications
["Diagnosis of selective tooth agenesis", "Familial risk assessment", "Clinical trial matching", "Confirmation of known familial variants"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21636-6 ICD-10: K00.0
Clinical summary
This genetic test analyzes the MSX1 gene to identify variants associated with selective tooth agenesis (congenital absence of permanent teeth). It utilizes Next-Generation Sequencing (NGS) for comprehensive detection of mutations.
TEST-5212
MTAP Gene Diaphyseal Medullary Stenosis with Malignant Fibrous Histiocytoma Genetic Test

This genetic test evaluates the MTAP gene for pathogenic variants associated with hereditary diaphyseal medullary stenosis and malignant fibrous histiocytoma.

Whole Blood (EDTA) / Buccal Swab / Extracted DNA 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["MTAP gene pathogenic variants", "Hereditary predisposition to sarcoma"]
Parameters
[]
Preparation
["Pre-test genetic counseling session is mandatory", "Do not discontinue or alter prescribed medication or surveillance schedules based solely on test results"]
Indications
["Diagnosis of diaphyseal medullary stenosis", "Diagnosis of malignant fibrous histiocytoma", "Strong family history of early-onset bone sarcoma", "Multiple bone infarcts", "Unexplained medullary abnormalities on imaging"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 91849-1 ICD-10: Q78.9, C49.9
Clinical summary
This genetic test evaluates the MTAP gene for pathogenic variants associated with hereditary diaphyseal medullary stenosis and malignant fibrous histiocytoma.
TEST-5287
MTM1 Gene Myotubular Myopathy X‑Linked Genetic Test

This test identifies pathogenic variants in the MTM1 gene to confirm X-linked myotubular myopathy (XLMTM) and identify carriers.

Peripheral Whole Blood or Dried Blood Spot (FTA Card) 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["MTM1 gene variants", "Single nucleotide variants", "Small insertions/deletions", "Copy number changes"]
Parameters
[]
Preparation
["Stay hydrated", "No specific fasting required"]
Indications
["Suspected X-linked myotubular myopathy", "Family history of XLMTM", "Carrier screening in females", "Prenatal diagnosis"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 56949-5 ICD-10: G71.2
Clinical summary
This test identifies pathogenic variants in the MTM1 gene to confirm X-linked myotubular myopathy (XLMTM) and identify carriers.

Category overview

Single Gene: overview

When clinical symptoms or family history point directly toward a specific inherited condition, highly focused genetic testing provides the exact, rapid insights necessary for peace of mind. Integrated into our advanced Molecular Genetics services, Single Gene testing meticulously analyzes one specific gene for known disease-causing mutations. Utilizing cutting-edge diagnostic technology, this highly focused molecular screening helps confirm or rule out precise genetic traits, safely guiding targeted medical interventions and family planning strategies. Recognized for specialized diagnostic excellence among diagnostic labs in the UAE, DNA Labs ensures absolute patient confidentiality, exceptional analytical precision, and incredibly efficient turnaround times. Take an informed step forward in your health journey—schedule your single gene testing in UAE, book a secure home sample collection, or reach out to our expert medical professionals.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.